ViiVHealthcare US

You are about to leave ViiVMedinfo.

By clicking "Allow," you will be taken to a website that is independent of ViiV Healthcare. The site you linking to is not controlled or endorsed by ViiV Healthcare, and ViiV Healthcare is not responsible for the content provided on that site.

APRETUDE

Apretude

Apretude

(cabotegravir long-acting for PrEP)

Apretude is an HIV-1 integrase strand transfer inhibitor (INSTI).

Prescribing Information, including boxed warning

Patient Information

Stability Tool

Medical Shorts

Apretude PK Tail

Management of the Pharmacokinetic Tail of Long-Acting Cabotegravir When Used as Pre-Exposure Prophylaxis

Resistance in patients receiving CAB LA for PrEP

Occurrence of Integrase Strand-Transfer Resistance in Patients Receiving Apretude for Pre-Exposure Prophylaxis

Time to Protection with Apretude When Used as PrEP

Time to Onset of Protection with Apretude When Used as Pre-Exposure Prophylaxis

Injection site reactions with APRETUDE

Injection-Site Reactions Associated with the Use of Long-Acting Cabotegravir for Pre-Exposure Prophylaxis

HIV Testing for PrEP

Related links

Learn more about PrEP

Registrational Trials

Connect with ViiV Medical Experts

Call 1-888-226-8434
Weekdays from 8 AM to 6 PM ET
(5 AM – 3 PM PT)

Find my ViiV MSL

Request a scientific discussion

Report an Adverse Event

To report SUSPECTED ADVERSE REACTIONS, contact ViiV Healthcare at https://gsk.public.reportum.com or 1-877-844-8872, or FDA at 1-800-FDA-1088 or http://www.fda.gov/medwatch.

ViiVHealthcare US

This site is intended for US Healthcare Professionals Only. It may include information about products or uses that have not been approved by the US Food and Drug Administration.

Trademarks are owned by or licensed to the ViiV Healthcare group of companies.

©2025 ViiV Healthcare group of companies or its licensor. Produced in USA. February 2025

  • Terms of Use
  • Cookie Policy
  • Privacy Notice
  • ViiVHealthcare.com